The FDA (Food and Drug Administration) has recently announced a voluntary recall of raw oysters and Manila clams after a potential link to a cluster of norovirus-like illnesses was discovered. This recall is a precautionary measure to ensure the safety of consumers and prevent further cases of illness.
According to the FDA, the recalled seafood products were distributed to several states including California, Oregon, Washington, and Nevada. The affected oysters and clams were harvested from the coast of Baja California, Mexico between February 12th and April 9th, 2021.
Norovirus is a highly contagious virus that can cause symptoms such as vomiting, diarrhea, and stomach cramps. While most people recover within 1-2 days, the illness can be more severe in young children, older adults, and individuals with weakened immune systems. The FDA became aware of the potential link to norovirus after receiving reports of several people falling ill after consuming raw oysters and Manila clams.
The recall was initiated by the distributor, Asuncion Live Seafood, after a routine FDA surveillance sampling found that the seafood products tested positive for norovirus. As a precautionary measure, the FDA is advising consumers not to consume any recalled seafood products and to dispose of them immediately. Retailers and food service operators are also urged to remove the affected products from their shelves and discontinue their sale.
Although the recall affects a relatively small batch of raw oysters and Manila clams, the FDA is taking swift action to ensure that the potential health risks are mitigated. Consumers are reminded to always handle raw seafood with caution and to cook it thoroughly before consumption. This will help ensure the elimination of any potential harmful bacteria or viruses.
The FDA is working closely with Asuncion Live Seafood and the local health authorities to investigate the source of contamination and prevent future occurrences. The company has also voluntarily suspended the distribution of the affected seafood products until the investigation is complete and steps have been taken to prevent a similar incident from happening again.
Consumers who have recently purchased raw oysters and Manila clams from the affected batches are advised to contact the place of purchase to receive a refund or dispose of the products safely.
The FDA is committed to protecting public health and will continue to monitor the situation closely. This recall serves as a reminder of the importance of food safety measures and the role that consumers, producers, and regulators play in ensuring the safety of our food supply.
We urge anyone who may have consumed the affected seafood products and experienced norovirus-like symptoms to seek medical attention immediately. Prompt medical attention is crucial to managing the illness and preventing its spread to others.
In summary, the FDA’s voluntary recall of raw oysters and Manila clams is a proactive and necessary step to protect consumers from the potential risk of norovirus. We encourage consumers to always follow proper food safety practices and stay informed about any recalls or potential health concerns regarding food products. Together, we can ensure the safety and well-being of our community.
